The Invisible Scholar: Authors of Legal Scholarship in Criminology and Criminal Justice Journals

This study assesses the authorship of legal scholarship within 20 criminology and criminal justice (CCJ) journals from 2005 through 2015, examining trends over time and variation across journals in the prevalence of sole-authorship and the mean number of authors and identifying the most prolific authors of legal scholarship published in CCJ journals. The study thus sheds light on the extent of collaboration among CCJ legal scholars and identifies CCJ legal scholars who have remained largely invisible due to their focus on a marginalized subfield

Persona Non Grata: The Marginalization of Legal Scholarship in Criminology and Criminal Justice Journals

Recently, concern has been voiced within the academy regarding the marginalization of legal scholarship within the criminology and criminal justice (CCJ) discipline. Although conventional wisdom and anecdotal evidence indicate that it is difficult to get legal scholarship published in CCJ journals, there is a dearth of empirical evidence on the representation of legal scholarship in CCJ journals. The present study assesses the representation of legal scholarship in 20 CCJ journals from 2005 through 2015, examining both trends over time and variation across journals. Findings indicate legal scholarship comprises a very small portion of articles published, there has been a steep decline in the number of legal articles published in recent years and the average number of legal articles per year is very low for nearly all of the journals in the sample. The implications of the marginalization of legal scholarship within the CCJ discipline are discussed

Safe efficacy of three strychnine alkaloid bait concentrations for hand-baiting control of plains pocket gophers

In November 1990, field efficacy studies using milo baits formulated with 0.35%, 0.75%, or 1.30% strychnine alkaloid were compared to a placebo (0.0% strychnine) for controlling plains pocket gophers (Geomys bursarius) near Pleasanton, Texas. These data were required by the US Environmental Protection Agency (EPA) as partial fulfillment for the maintenance of the rodenticide registrations of the US Department of Agriculture. Each of four treatment units (TUs) within a block (2) was randomly assigned one of the four baits. Within each TU, 15 gophers were captured (balanced roughly for gender) and instrumented with radio transmitters. Following a pretreatment acclimation averaging 4.1 days, bait (4 g) was placed in active pocket gopher burrows by hand-baiting. Pocket gopher mortality was measured by monitoring the fate of radio-equipped pocket gophers (n=123) both pretreatment and post-treatment. Lack of gopher movement on two consecutive days indicated death, and the carcass was retrieved. Strychnine mortality was based on chemical analyses of carcasses, and it occurred in 0.0%, 66.7%, 96.3%, and 89.7% of gophers from the 0.0%, 0.35%, 0.75% and 1.30% TUs, respectively. Natural mortality was 7% on the placebo TUs. All three strychnine treatments provided significantly increased mortality over the placebo (P\u3c0.0001) using Fisher\u27s exact test for paired comparisons. A difference in gopher mortality occurred between the 0.32% and 0.77% strychnine treatments (P=0.003), but not between the other comparisons (0.32% vs 1.30%, P=0.18 and 0.77% vs. 1.30%, P=0.24). Gopher carcasses recovered post-treatment indicated 68 of 86 (79.1%) had strychnine alkaloid residues. The non-target strychnine hazard (using least squares means) by treatment were 4.85 ppm (0.35%), 8.04 ppm (0.75%), and 9.47 ppm (1.30%). Carcass residue differences were not detected among strychnine treatments (F=2.48, df=2,3, P=0.23). Fortunately, non-target exposure was greatly decreased because all carcasses with strychnine residues were recovered underground at a mean depth of 0.51 m (SE=0.027, range 0.15–1.17 m). Placebo-baited TUs had 27 survivors and 2 deaths from unknown causes. None had detectable strychnine levels. No non-target mortalities were documented during carcass searches and radio-tracking activities

Risk factors for 1-year mortality after thoracic endovascular aortic repair

ObjectiveThoracic endovascular aortic repair, although physiologically well tolerated, may fail to confer significant survival benefit in some high-risk patients. In an effort to identify patients most likely to benefit from intervention, the present study sought to determine the risk factors for 1-year mortality after thoracic endovascular aortic repair.MethodsA retrospective review was performed on prospectively collected data from all patients undergoing thoracic endovascular aortic repair from 2002 to 2010 at a single institution. Univariate analysis and multivariate Cox proportional hazards regression analysis were used to identify risk factors associated with mortality within 1 year after thoracic endovascular aortic repair.ResultsDuring the study period, 282 patients underwent at least 1 thoracic endovascular aortic repair; index procedures included descending aortic repair (n = 189), hybrid arch repair (n = 55), and hybrid thoracoabdominal repair (n = 38). The 30-day/in-hospital mortality was 7.4% (n = 21) and the overall 1-year mortality was 19% (n = 54). Cardiopulmonary pathologies were the most common cause of nonperioperative 1-year mortality (22%, n = 12). Multivariate modeling demonstrated 3 variables independently associated with 1-year mortality: age older than 75 years (hazard ratio, 2.26; P = .005), aortic diameter greater than 6.5 cm (hazard ratio, 2.20; P = .007), and American Society of Anesthesiologists class 4 (hazard ratio, 1.85; P = .049). A baseline creatinine greater than 1.5 mg/dL (hazard ratio, 1.79; P = .05) and congestive heart failure (hazard ratio, 1.87; P = .08) were also retained in the final model. These 5 variables explained a large proportion of the risk of 1-year mortality (C statistic = 0.74).ConclusionsAge older than 75 years, aortic diameter greater than 6.5 cm, and American Society of Anesthesiologists class 4 are independently associated with 1-year mortality after thoracic endovascular aortic repair. These clinical characteristics may help risk-stratify patients undergoing thoracic endovascular aortic repair and identify those unlikely to derive a long-term survival benefit from the procedure

The effects of ecstasy' (MDMA) on visuospatial memory performance: findings from a systematic review with meta-analyses

To review, with meta-analyses where appropriate, performance differences between ecstasy (3,4-methylenedioxymethamphetamine) users and non-users on a wider range of visuospatial tasks than previously reviewed. Such tasks have been shown to draw upon working memory executive resources. Abstract databases were searched using the United Kingdom National Health Service Evidence Health Information Resource. Inclusion criteria were publication in English language peer-reviewed journals and the reporting of new findings regarding human ecstasy-users' performance on visuospatial tasks. Data extracted included specific task requirements to provide a basis for meta-analyses for categories of tasks with similar requirements. Fifty-two studies were identified for review, although not all were suitable for meta-analysis. Significant weighted mean effect sizes indicating poorer performance by ecstasy users compared with matched controls were found for tasks requiring recall of spatial stimulus elements, recognition of figures and production/reproduction of figures. There was no evidence of a linear relationship between estimated ecstasy consumption and effect sizes. Given the networked nature of processing for spatial and non-spatial visual information, future scanning and imaging studies should focus on brain activation differences between ecstasy users and non-users in the context of specific tasks to facilitate identification of loci of potentially compromised activity in users. Keywords: ecstasy (MDMA); visuospatial; memory; meta-analyse